相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII
Takumi Maruhashi et al.
NATURE IMMUNOLOGY (2018)
Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
Peter Jonsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Xiaobo Mao et al.
SCIENCE (2016)
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers
Christopher J. Holland et al.
JOURNAL OF IMMUNOLOGY (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
Alexander Pedroza-Gonzalez et al.
ONCOIMMUNOLOGY (2015)
Antibody Stabilization of Peptide-MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs
Katie Tungatt et al.
JOURNAL OF IMMUNOLOGY (2015)
LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
Feng Xu et al.
CANCER RESEARCH (2014)
Modulators of Protein-Protein Interactions
Lech-Gustav Milroy et al.
CHEMICAL REVIEWS (2014)
Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
Emanuela I. Sega et al.
PLOS ONE (2014)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Structural and biophysical determinants of aß T-cell antigen recognition
John S. Bridgeman et al.
IMMUNOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4+ T-cell repertoire selection
David K. Cole et al.
NATURE COMMUNICATIONS (2012)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation
Ruth K. Moysey et al.
PROTEIN & CELL (2010)
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II
Bitao Liang et al.
JOURNAL OF IMMUNOLOGY (2008)
A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells
Chrystelle Brignone et al.
JOURNAL OF IMMUNOLOGY (2007)
Human TCR-Binding affinity is governed by MHC class restriction
David K. Cole et al.
JOURNAL OF IMMUNOLOGY (2007)
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab
Rhona Stein et al.
BLOOD (2006)
Evaluation of α-D-mannopyranoside glycolipid micelles-lectin interactions by surface plasmon resonance method
Bandaru Narasimha Murthy et al.
GLYCOBIOLOGY (2006)
Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function
Siyuan Liang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)
NY Li et al.
JOURNAL OF IMMUNOLOGY (2004)
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)
S Andreae et al.
BLOOD (2003)
LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination
F Triebel
TRENDS IN IMMUNOLOGY (2003)
Cutting edge: Molecular analysis of the negative regulatory function of lymphocyte activation gene-3
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
